Search Grant Opportunities

Hereditary Hemorrhagic Telangiectasia (HHT) Center

ID: HRSA-25-030 • Type: Forecasted

Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) program is to reduce morbidity and mortality associated with HHT by: 1) expanding access to and coordination of care for HHT patients; and 2) developing a de-identified, aggregate patient data registry to better understand this rare disease and treatment outcomes.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 7/25/24 Health Resources and Services Administration forecasted grant opportunity HRSA-25-030 for Hereditary Hemorrhagic Telangiectasia (HHT) Center with funding of $1.8 million. The grant will be issued under grant program 93.110 Maternal and Child Health Federal Consolidated Programs. It is expected that one grant will be made.

Timing

Forecast Posted Date
July 25, 2024, 12:00 a.m. EDT
Est. Application Posting Date
April 21, 2025, 12:00 a.m. EDT
Est. Synopsis Response Date
June 20, 2025, 12:00 a.m. EDT Forecasted
Last Updated
March 10, 2025, 2:40 p.m. EDT
Version
4

Eligibility

Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Public Entities, Institutions of Higher Education, Tribes and Tribal Organizations, For-profit organizations, Small businesses, Nonprofits

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$1,800,000
Estimated Number of Grants
1

Contacts

Contact
Nordia Williams
Contact Email

Documents

Posted documents for HRSA-25-030

Potential Applicants and Partners

Awardees that have recently won grants similar to HRSA-25-030

Incumbent or Similar Grants

Grants similar to HRSA-25-030

Similar Active Opportunities

Open grant opportunities similar to HRSA-25-030